Table 2.
Findings on [68Ga]RM2 PET/CT compared to current biopsy.
| Pat. No. | Rating RM2 PET |
Sites of Metastatic Disease | No. of Metastases | Current Biopsy | ||
|---|---|---|---|---|---|---|
| Site | ER Status | Time Interval to PET (Months) | ||||
| 1 | Positive | OSS, LN, HEP | 7 | HEP | >90% | 5 (after) |
| 2 | Negative | OSS, LN | >10 | Pleural effusion | 0% | 4 (after) |
| 3 | Positive | OSS | 5 | OSS | >90% | 1 (before) |
| 4 | Positive | OSS | 1 | OSS | >90% | 1 (before) |
| 5 | Negative | OSS | 4 * | Local relapse | >90% | 17 (before) |
| 6 | Positive | OSS, LN | 9 | Primary tumor | >90% | 4 (before) |
| 7 | Positive | OSS, LN, HEP | >30 | OSS | >90% | 22 (before) |
| 8 | Positive | OSS | 1 | OSS | >90% | 1 (before) |
Abbreviations: OSS: bone, HEP: liver, LN: lymph node; * verified by [18F]FDG PET/MRI.